Can Fite Biofarma Stock (AMEX: CANF) stock price, news, charts, stock research, profile.
Open | $4.55 |
Close | $3.81 |
Volume / Avg. | 321.46K / 82.80K |
Day Range | 3.75 - 4.69 |
52 Wk Range | 1.81 - 4.69 |
Market Cap | $19.01M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 51 |
Short Interest | - |
Days to Cover | 1.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Can Fite Biofarma (AMEX:CANF) through any online brokerage.
Other companies in Can Fite Biofarma’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), GlycoMimetics (NASDAQ:GLYC), Viracta Therapeutics (NASDAQ:VIRX) and MEI Pharma (NASDAQ:MEIP).
There is no analysis for Can Fite Biofarma.
Can Fite Biofarma has a consensus price target of $14.00.
The stock price for Can Fite Biofarma (AMEX: CANF) is $3.81 last updated Today at July 22, 2024 at 8:00 PM EDT.
There are no upcoming dividends for Can Fite Biofarma.
Can Fite Biofarma’s Q1 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Can Fite Biofarma.
Can Fite Biofarma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.